FR2899477B1 - Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t - Google Patents

Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Info

Publication number
FR2899477B1
FR2899477B1 FR0651271A FR0651271A FR2899477B1 FR 2899477 B1 FR2899477 B1 FR 2899477B1 FR 0651271 A FR0651271 A FR 0651271A FR 0651271 A FR0651271 A FR 0651271A FR 2899477 B1 FR2899477 B1 FR 2899477B1
Authority
FR
France
Prior art keywords
glycosides
lymphocytes
activator
lactose
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0651271A
Other languages
English (en)
Other versions
FR2899477A1 (fr
Inventor
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0651271A priority Critical patent/FR2899477B1/fr
Priority to PCT/EP2007/053386 priority patent/WO2007116023A1/fr
Priority to EP07727854A priority patent/EP2012743A1/fr
Priority to CNA2007800212376A priority patent/CN101466351A/zh
Priority to US12/296,311 priority patent/US20100160251A1/en
Publication of FR2899477A1 publication Critical patent/FR2899477A1/fr
Application granted granted Critical
Publication of FR2899477B1 publication Critical patent/FR2899477B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
FR0651271A 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t Expired - Fee Related FR2899477B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0651271A FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t
PCT/EP2007/053386 WO2007116023A1 (fr) 2006-04-07 2007-04-05 Utilisation de c-glycosides dérivé de lactose comme agent protecteur et/ou activateur des lymphocytes gamma delta t
EP07727854A EP2012743A1 (fr) 2006-04-07 2007-04-05 Composes d'imidazole
CNA2007800212376A CN101466351A (zh) 2006-04-07 2007-04-05 乳糖的衍生C-糖苷作为γδT淋巴细胞保护剂和/或激活剂的用途
US12/296,311 US20100160251A1 (en) 2006-04-07 2007-04-05 Imidazo compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0651271A FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Publications (2)

Publication Number Publication Date
FR2899477A1 FR2899477A1 (fr) 2007-10-12
FR2899477B1 true FR2899477B1 (fr) 2008-05-30

Family

ID=37311842

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0651271A Expired - Fee Related FR2899477B1 (fr) 2006-04-07 2006-04-07 Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t

Country Status (5)

Country Link
US (1) US20100160251A1 (fr)
EP (1) EP2012743A1 (fr)
CN (1) CN101466351A (fr)
FR (1) FR2899477B1 (fr)
WO (1) WO2007116023A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8217164B2 (en) * 2006-04-07 2012-07-10 L'oreal Use of a lactose-derived C-glycoside compound as an agent for activating and regulating cutaneous immunity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2818646B1 (fr) * 2000-12-22 2006-06-23 Oreal Nouveaux derives c-glycoside et utilisation
FR2818547B1 (fr) * 2000-12-22 2006-11-17 Oreal Nouveaux derives c-glycosides et utilisation
FR2869317B1 (fr) * 2004-04-23 2008-08-29 Oreal Nouveaux derives c-glycosides et utilisations cosmetiques
FR2882516B1 (fr) * 2005-02-25 2007-05-25 Oreal Utilisation capillaire des derives c-glycosides

Also Published As

Publication number Publication date
US20100160251A1 (en) 2010-06-24
EP2012743A1 (fr) 2009-01-14
FR2899477A1 (fr) 2007-10-12
WO2007116023A1 (fr) 2007-10-18
CN101466351A (zh) 2009-06-24

Similar Documents

Publication Publication Date Title
FR2899467B1 (fr) Utilisation de derive c-glycosides comme agent protecteur et/ou activateur des lymphocytes gamma delta t
HK1138833A1 (en) Carboxamide compounds and their use as calpain inhibitors
SE0601155L (sv) Gas- och vätsketät skyddsdräkt
EP1812049A4 (fr) Inhibiteurs de kallikreine et leurs utilisations
IL192906A0 (en) Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
EP2115570A4 (fr) Agents de protection et modes de privilège
IL197161A0 (en) Derivatives of 4-(n-azacycloalkyl)anilides and compositions containing the same
PL1963451T3 (pl) Przekładka rozdzielająca do klejów przylepcowych i sposób jej użycia
DE602007007839D1 (de) Helm und Verfahren zu dessen Abnahme
ZA200809355B (en) Novel piperazine compound, and use thereof as HCV polymerase inhibitor
IL189217A0 (en) Bridged n-bicylic sulfonamido inhibitors of gamma secretase
EP2382267A4 (fr) Copolymères à blocs acryliques pour aérosols et adhésifs en aérosol
HK1137756A1 (en) Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors hif--4-
SE0702581L (sv) Idrottshandske med handledsskydd
FR2899469B1 (fr) Utilisation de derive de d- et l-fucose comme agent protecteur et/ou activateur des lymphocytes gamma delta t
FR2899468B1 (fr) Utilisation de c-glycosides derives de galactose comme agent protecteur et/ou activateur des lumphocytes gamma delta t
FR2899588B1 (fr) Utilisation de compose c-glycoside derive de galactose comme agent activateur et regulateur de l'immunite cutanee
FR2899477B1 (fr) Utilisation de c-glycosides derive de lactose comme agent protecteur et/activateur des lymphocytes gamma delta t
GB2438067B (en) Cooling and protecting mammalian bodies
EP2127672A4 (fr) Inhibiteur d'une infection par l'herpèsvirus, procédé d'inhibition d'une infection par l'herpèsvirus et son utilisation
ZA200605749B (en) Combination of voriconazole and an antifungal CYP2C19 Inhibitor
FR2899464B1 (fr) Compose c-glycoside et utilisation comme agent activateur et regulateur de l'immunite cutanee
EP2101575A4 (fr) Composés activateurs de l'ace2 et procédés d'utilisation de ceux-ci
GB2425778B8 (en) Protection of reinforcing steel
EP1744755A4 (fr) Composes et compositions utilises en tant qu'inhibiteurs de la cathepsine

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121228